학술논문
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
Document Type
Article
Author
Wrangle, J.M.; Garrett-Mayer, E.; Hill, E.G.; Ravenel, J.G.; Anderton, K.; Lindsey, K.; Taffaro-Neskey, M.; Sherman, C.; Suriano, S.; Swiderska-Syn, M.; Sion, A.; Harris, J.; Edwards, A.R.; Krieg, C.; Rubinstein, M.P.; Velcheti, V.; Patel, M.R.; Miller, J.S.; Egan, J.O.; Rhode, P.R.; Jeng, E.K.; Rock, A.D.; Wong, H.C.; Farhad, M.; Redmond, W.L.; Rytlewski, J.A.; Sanders, C.M.; Yusko, E.C.; Robinson, M.D.
Source
In: The Lancet Oncology . (The Lancet Oncology, May 2018, 19(5):694-704)
Subject
Language
English
ISSN
14745488
14702045
14702045